Global Bio-imaging Market

Global Bio-imaging Market, By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound , X-ray, Others), By End User (Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.

Market Dynamics:

Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.

Key features of the study:
  • This report provides an in-depth analysis of the global bio-imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bio-imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market
Detailed Segmentation:
  • Global Bio-imaging Market Segmentation, By Imaging Modality:
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Position Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Others
  • Global Bio-imaging Market Segmentation, By End User:
  • Hospitals & diagnostic centers
  • Academic & research institutes
  • Pharmaceutical & biotech companies
  • Others
  • Global Bio-imaging Market Segmentation, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Top Companies in Global Bio-imaging Market:
  • Bracco Imaging S.P.A
  • Bayer HealthCare Pharmaceuticals
  • Esaote S.p.A
  • Digirad Corporation
  • FONAR Corporation
  • GE Healthcare
  • Hologic Inc
  • Hitachi Medical Corporation
  • Lantheus Medical Imaging, Inc.
  • Covidien Pharmaceuticals
  • Mindray Medical International Limited.
  • Gamma Medica Inc
  • Samsung Medison Co., Ltd.
  • Philips Healthcare


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Bio-imaging, By Imaging Modality
Market Bio-imaging, By End User
Market Bio-imaging, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Technological advancements in bio-imaging modalities
Restraints
High capital investment requirements
Opportunities
Hybrid imaging systems
Key Highlights
Regulatory Scenario
Recent Trends
PEST Analysis
PORTER’s Analysis
Mergers, Acquisitions, and Collaborations
4. Global Bio-imaging Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Bio-imaging Market, By Imaging Modality, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Magnetic Resonance Imaging (MRI)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Computed Tomography (CT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Position Emission Tomography (PET)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Ultrasound
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
X-ray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Bio-imaging Market, By End User, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Hospitals & diagnostic centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Academic & research institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pharmaceutical & biotech companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Bio-imaging Market, By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2019 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Company Profile
Bracco Imaging S.P.A
Company Highlights
Imaging Modality Portfolio
Key Developments
Financial Performance
Strategies
Bayer HealthCare Pharmaceuticals
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Esaote S.p.A
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Digirad Corporation
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
FONAR Corporation
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
GE Healthcare
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Hologic Inc
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Hitachi Medical Corporation
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Lantheus Medical Imaging, Inc.
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Covidien Pharmaceuticals
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Mindray Medical International Limited.
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Gamma Medica Inc
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Samsung Medison Co., Ltd.
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Philips Healthcare
Company Highlights
Imaging Modality Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
9. Section
References
Research Methodology
About us
*Browse 26 market data tables and 30 figures on "Global Bio-imaging Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings